newsfilter
← Latest News
Business Wire·

Abiomed Announces Record Revenue of $261 Million, up 13% Year Over Year

Increasing Low End of Guidance: $1,025 Million - $1,030 Million, up 21% - 22% ABIOMED, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced financial results for the quarter ended December 31, 2021. Q3